Multi-Drug Resistance 1 Gene C3435T Polymorphism in Migraine Patients: A Case-Control Study
Abstract
Background: Migraine is a complex neurovascular disorder with a substantial genetic component. The multidrug resistance 1 (MDR1/ABCB1) gene encodes P-glycoprotein, a key efflux transporter at the blood–brain barrier that regulates the distribution of neuroactive compounds. The functional C3435T polymorphism (rs1045642) has been suggested to influence transporter activity; however, its role in migraine susceptibility remains inconclusive. Methods: This case–control study included 100 patients with migraine diagnosed according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) and 100 age- and sex-matched healthy controls. Genotyping of the MDR1 C3435T polymorphism was performed using the polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) method. Genotype and allele distributions were analyzed under different genetic models. Multivariate logistic regression analysis was conducted to adjust for potential confounders, including age, sex, body mass index, and biochemical parameters. Bonferroni and false discovery rate (FDR) corrections were applied to account for multiple comparisons. Results: Genotype distributions were consistent with the Hardy–Weinberg equilibrium in both groups (p > 0.05). The overall genotype distribution did not differ significantly between migraine patients and controls (χ2 = 4.54, p = 0.103). However, the TT genotype was significantly more frequent in the migraine group (40.0% vs. 30.0%; odds ratio…
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 100 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.